APA (7th ed.) Citation

M, S., E, R., PG, S., JW, J., M, S., DL, B., . . . GG, S. (2024). Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES. European journal of preventive cardiology, 31(10), e75. https://doi.org/10.1093/eurjpc/zwae110

Chicago Style (17th ed.) Citation

M, Szarek, et al. "Comparison of Change in Lipoprotein(a) Mass and Molar Concentrations by Alirocumab and Risk of Subsequent Cardiovascular Events in ODYSSEY OUTCOMES." European Journal of Preventive Cardiology 31, no. 10 (2024): e75. https://doi.org/10.1093/eurjpc/zwae110.

MLA (9th ed.) Citation

M, Szarek, et al. "Comparison of Change in Lipoprotein(a) Mass and Molar Concentrations by Alirocumab and Risk of Subsequent Cardiovascular Events in ODYSSEY OUTCOMES." European Journal of Preventive Cardiology, vol. 31, no. 10, 2024, p. e75, https://doi.org/10.1093/eurjpc/zwae110.